Chiba’s Precision System Science Enters Test Agent Business
This article was originally published in PharmAsia News
Executive Summary
Chiba-based Precision System Science enters the test agent business and is promoting its own brand products. The company is marketing legionella bacterium and tubercle bacillus test agents, and plans to launch gene extraction products by the end of the year. PSS has a history of being an original design manufacturer, but to maximize profit margin, the company decided to market its own testing devices along with test agents. (Click here for more - Japanese language
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.